Corrigendum to “Lifetime risk of autosomal recessive mitochondrial disorders calculated from genetic databases” [EBioMedicine 54 (2020) 102730]

• Jing Tan,
• Matias Wagner,
• Sarah L. Stenton,
• Tim M. Strom,
• Saskia B. Wortmann,
• Holger Prokisch,
• Thomas Meitinger,
• Konrad Oexle,
• Thomas Klopstock

Affiliations

Jing Tan

Institute of Human Genetics, School of Medicine, Technische Universität München, Munich, Germany; Friedrich-Baur-Institute, Department of Neurology, University Hospital, LMU Munich, Munich, Germany

Matias Wagner

Institute of Human Genetics, School of Medicine, Technische Universität München, Munich, Germany; Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany; Institute of Neurogenomics, Helmholtz Zentrum München, Neuherberg, Germany; Corresponding author at: Institute of Human Genetics, School of Medicine, Technische Universität München, Munich, Germany.

Sarah L. Stenton

Institute of Human Genetics, School of Medicine, Technische Universität München, Munich, Germany; Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany

Tim M. Strom

Institute of Human Genetics, School of Medicine, Technische Universität München, Munich, Germany; Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany

Saskia B. Wortmann

Institute of Human Genetics, School of Medicine, Technische Universität München, Munich, Germany; Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany; Department of Pediatrics, University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria

Holger Prokisch

Institute of Human Genetics, School of Medicine, Technische Universität München, Munich, Germany; Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany

Thomas Meitinger

Institute of Human Genetics, School of Medicine, Technische Universität München, Munich, Germany; Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany

Konrad Oexle

Institute of Neurogenomics, Neurogenetic Systems Analysis Unit, Helmholtz Zentrum München, Neuherberg, Germany

Thomas Klopstock

Friedrich-Baur-Institute, Department of Neurology, University Hospital, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Corresponding author at: Friedrich-Baur-Institute, Department of Neurology, University Hospital, LMU Munich, Munich, Germany.